Protalix BioTherapeutics

PLX

Börsenwert 211 Mio. $

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
26	26 Wells Fargo San Francisco, California	157.389 $	+86.883 $	+41.027	+155 %
27	27 Bailard Foster City, California	142.363 $	+129.391 $	+61.100	Neu
28	28 State of Wyoming Cheyenne, Wyoming	137.887 $	+125.323 $	+59.179	Neu
29	29 Winton Group London, United Kingdom	130.482 $	+118.593 $	+56.001	Neu
30	30 T. Rowe Price Associates Baltimore, Maryland	125.000 $	–	–	–
31	31 Bank of America Charlotte, North Carolina	120.918 $	-57.565 $	-27.183	-34 %
32	32 Morgan Stanley New York	120.405 $	-529.673 $	-250.117	-83 %
33	33 RhumbLine Advisers Boston, Massachusetts	107.697 $	+862 $	+407	+0,9 %
34	34 MetLife Investment Management Whippany, New Jersey	106.015 $	+3.818 $	+1.803	+4 %
35	35 Two Sigma Investments New York	99.060 $	+51.642 $	+24.386	+135 %
36	36 Franklin Resources San Mateo, California	96.262 $	+87.491 $	+41.314	Neu
37	37 Susquehanna International Group Bala Cynwyd, Pennsylvania	95.400 $	-17.240 $	-8.141	-17 %
38	38 Phoenix Financial Givatayim, Israel	92.921 $	–	–	–
39	39 Invesco Atlanta, Georgia	85.548 $	-22.630 $	-10.686	-23 %
40	40 Citigroup New York	80.825 $	+67.197 $	+31.731	+1.073 %
41	41 Mirae Asset Global ETFs Holdings Causeway Bay, Hong Kong	79.446 $	+74 $	+35	+0,1 %
42	42 New York State Common Retirement Fund Albany, New York	72.463 $	–	–	–
43	43 Aptus Capital Advisors Fairhope, Alabama	65.161 $	+1.557 $	+735	+3 %
44	44 Smartleaf Asset Management Boston, Massachusetts	61.041 $	–	–	–
45	CPA 45 Capital Performance Advisors Walnut Creek, California	60.522 $	-161 $	-76	-0,3 %
46	46 Point72 Asset Management Stamford, Connecticut	59.569 $	+54.141 $	+25.566	Neu
47	47 Simplex Trading Chicago, Illinois	58.361 $	+5.034 $	+2.377	+10 %
48	48 Russell Investments Group London, United Kingdom	57.702 $	+26.503 $	+12.515	+102 %
49	49 Prelude Capital Management New York	52.891 $	+8.047 $	+3.800	+20 %
50	50 AllianceBernstein Nashville, Tennessee	52.427 $	+26.344 $	+12.440	+106 %

Protalix BioTherapeutics PLX Börsenwert 211 Mio. $

Protalix BioTherapeutics

PLX

Börsenwert 211 Mio. $